Kevin Hykes - Net Worth and Insider Trading

Kevin Hykes Net Worth

The estimated net worth of Kevin Hykes is at least $372,360 dollars as of 2024-09-13. Kevin Hykes is the PRES & CEO of CVRx Inc and owns about 30,000 shares of CVRx Inc (CVRX) stock worth over $228,900. Kevin Hykes is also the Director of Hansen Medical Inc and owns about 35,955 shares of Hansen Medical Inc (HNSN) stock worth over $143,460. Details can be seen in Kevin Hykes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Hykes has not made any transactions after 2024-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin Hykes

To

Kevin Hykes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Hykes owns 1 companies in total, including CVRx Inc (CVRX) .

Click here to see the complete history of Kevin Hykes’s form 4 insider trades.

Insider Ownership Summary of Kevin Hykes

Ticker Comapny Transaction Date Type of Owner
CVRX CVRx Inc 2024-08-05 director

Kevin Hykes Latest Holdings Summary

Kevin Hykes currently owns a total of 2 stocks. Among these stocks, Kevin Hykes owns 30,000 shares of CVRx Inc (CVRX) as of August 5, 2024, with a value of $228,900 and a weighting of 61.47%. Kevin Hykes also owns 35,955 shares of Hansen Medical Inc (HNSN) as of July 30, 2013, with a value of $143,460 and a weighting of 38.53%.

Latest Holdings of Kevin Hykes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CVRX CVRx Inc 2024-08-05 30,000 7.63 228,900
HNSN Hansen Medical Inc 2013-07-30 35,955 3.99 143,460

Holding Weightings of Kevin Hykes


Kevin Hykes Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Hykes has made a total of 1 transactions in CVRx Inc (CVRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CVRx Inc is the acquisition of 30,000 shares on August 5, 2024, which cost Kevin Hykes around $250,800.

According to the SEC Form 4 filings, Kevin Hykes has made a total of 0 transactions in Hansen Medical Inc (HNSN) over the past 5 years. The most-recent trade in Hansen Medical Inc is the acquisition of 28,455 shares on July 30, 2013, which cost Kevin Hykes around $35,000.

Insider Trading History of Kevin Hykes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Hykes Trading Performance

GuruFocus tracks the stock performance after each of Kevin Hykes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Hykes is 29.16%. GuruFocus also compares Kevin Hykes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Hykes within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Hykes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Hykes

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.48 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.87 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin Hykes Ownership Network

Ownership Network List of Kevin Hykes

No Data

Ownership Network Relation of Kevin Hykes

Insider Network Chart

Kevin Hykes Owned Company Details

What does CVRx Inc do?

Who are the key executives at CVRx Inc?

Kevin Hykes is the director of CVRx Inc. Other key executives at CVRx Inc include Chief Marketing Officer Paul Verrastro , 10 percent owner Johnson & Johnson , and 10 percent owner Johnson & Johnson Innovation - Jjdc, Inc. .

CVRx Inc (CVRX) Insider Trades Summary

Over the past 18 months, Kevin Hykes made 1 insider transaction in CVRx Inc (CVRX) with a net purchase of 30,000. Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 8,500 shares made by Joseph P Slattery , a net sale of 4,295 shares made by Paul Verrastro , and a net sale of 3,725 shares made by Johnson & Johnson .

In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 38,500 shares, with a net purchase of 38,500 shares. During the past 18 months, 8,020 shares of CVRx Inc (CVRX) were sold and 38,500 shares were bought by its insiders, resulting in a net purchase of 30,480 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CVRx Inc Insider Transactions

No Available Data

Kevin Hykes Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Hykes. You might contact Kevin Hykes via mailing address: 2 Goodyear, Suite B, Irvine Ca 92618.

Discussions on Kevin Hykes

No discussions yet.